| Literature DB >> 35203758 |
Lisa Knoche1,2, Jan Lisec1, Tanja Schwerdtle2,3, Matthias Koch1.
Abstract
The drug salinomycin (SAL) is a polyether antibiotic and used in veterinary medicine as coccidiostat and growth promoter. Recently, SAL was suggested as a potential anticancer drug. However, transformation products (TPs) resulting from metabolic and environmental degradation of SAL are incompletely known and structural information is missing. In this study, we therefore systematically investigated the formation and identification of SAL derived TPs using electrochemistry (EC) in an electrochemical reactor and rat and human liver microsome incubation (RLM and HLM) as TP generating methods. Liquid chromatography (LC) coupled to high-resolution mass spectrometry (HRMS) was applied to determine accurate masses in a suspected target analysis to identify TPs and to deduce occurring modification reactions of derived TPs. A total of 14 new, structurally different TPs were found (two EC-TPs, five RLM-TPs, and 11 HLM-TPs). The main modification reactions are decarbonylation for EC-TPs and oxidation (hydroxylation) for RLM/HLM-TPs. Of particular interest are potassium-based TPs identified after liver microsome incubation because these might have been overlooked or declared as oxidated sodium adducts in previous, non-HRMS-based studies due to the small mass difference between K and O + Na of 21 mDa. The MS fragmentation pattern of TPs was used to predict the position of identified modifications in the SAL molecule. The obtained knowledge regarding transformation reactions and novel TPs of SAL will contribute to elucidate SAL-metabolites with regards to structural prediction.Entities:
Keywords: HRMS; electrochemistry; ionophore antibiotics; rat/human liver microsomes; salinomycin; transformation product
Year: 2022 PMID: 35203758 PMCID: PMC8868298 DOI: 10.3390/antibiotics11020155
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1Chemical structure of salinomycin (SAL) as sodium-complex.
Overview of literature described metabolites or degradation products of salinomycin ordered by the transformation reaction.
| Transformation Reaction | Experiment | References |
|---|---|---|
| degradation by poultry litter | [ | |
| degradation by broiler litter | [ | |
| manure storage | [ | |
| hydrolysis (acid-catalyzed) | [ | |
| treatment with formic acid | [ | |
| photodegradation | [ | |
| transformation in soil | [ | |
| microbial decomposition | [ | |
| hydrolysis (acid-catalyzed) | [ | |
| treatment with formic acid | [ | |
| photodegradation | [ | |
| Hydroxylation (+O) | human hepatoma cells (HepG2) | [ |
| primary human hepatocytes (PHH) | [ | |
| rat primary hepatocytes (PRH) | [ | |
| rat hepatoma cells (FaO) | [ | |
| Hydroxylation + Demethylation | photodegradation | [ |
| human hepatoma cells (HepG2) | [ | |
| primary human hepatocytes (PHH) | [ | |
| Di-/Tri-hydroxylation | photodegradation | [ |
| primary human hepatocytes (PHH) | [ | |
| rat primary hepatocytes (PRH) | [ | |
| Dehydrogenation | rat primary hepatocytes (PRH) | [ |
| Isomeric changes | hydrolysis (acid-catalyzed) | [ |
Figure 2Online ECR/HRMS measurements of SAL (A) Mass spectra of SAL at a potential of 1.0 V (upper spectrum) and 2.0 V (lower spectrum). (B) 3D mass voltammogram of SAL. Mass traces (m/z) of the TPs of SAL as [M + Na]+ in dependence of the applied oxidation potential ramped from 0 to 2.5 V.
The intensity is calculated in relation to the highest TP-signal (m/z-trace 759) vs. (very strong) > 60%, s (strong): 40–60%, m (moderate): 20–40%, w (weak) 10–20%, vw (very weak) < 10%).
| EC-TP | Mass | Mass | Sum Formula | Suggested Modification | Intensity |
|---|---|---|---|---|---|
| 1 * | 791.4801 | 791.4795 | C41H70O12NNa | −CO, +2O, −4H, +NH4 | vw |
| 2 | 786.5116 | 786.5108 | C41H74O10NNa2 | −CO, +NH4, + Na | m |
| 3 | 777.4804 | 777.4764 | C41H70O12Na | −CO, +2O | vw |
| 4 | 759.4956 | 759.5000 | C42H72O10Na | −O, +2H | vs |
| 5 § | 745.4859 | 745.4866 | C41H70O10Na | −CO | vs |
| 6 * | 743.4710 | 743.4710 | C41H68O10Na | −CO, −2H | m |
| 7 § | 727.4764 | 727.4761 | C41H68O9Na | −CO, −H2O | s |
| 8 | 717.4552 | 717.4553 | C39H66O10Na | −CO, −C2H4 | vw |
| 9 | 687.4817 | 687.4811 | C39H68O8Na | −CO, −CO2, −CH2 | w |
| 10 * | 669.4732 | 669.4706 | C39H66O7Na | −CO, −CO2, −CH2, −H2O | w |
| 11 * | 651.4621 | 651.4600 | C39H64O6Na | −CO, −CO2, −CH2, −2H2O | vw |
| SAL | 773.4816 | 773.4815 | C42H70O11Na |
* EC-TPs indicated by an asterisk are potential ESI in source fragments. § These EC-TPs have been confirmed in offline measurements.
Figure 3Simplified presentation of the fragmentation pattern of SAL (proposed by Miao et al. [26]). Four major fragments were used for structural prediction.
Figure 4Proposed structures of the TPs derived from EC experiments with SAL using GC electrode. The dotted circles mark the areas of modification. The red highlighted oxygen-atoms of EC-TP2 could be involved in a loss of water.
Detected TPs of SAL in a liver microsome assay. The intensity is calculated in relation to the highest TP-signal vs (very strong) > 60%, s (strong): 40–60%, m (moderate): 20–40%, w (weak) 10–20%, vw (very weak) < 10%).
| rt [s] | Mass Meas. | Mass Calc. | Sum Formula | Suggested Modification | Intensity | |
|---|---|---|---|---|---|---|
| HLM | ||||||
| TP-R1 | 65.20 | 821.4456 | 821.4453 | C42H70O13K | −Na, +2O, +K | vw |
| TP-R2 | 81.35 | 805.4510 | 805.4504 | C42H70O12K | −Na, +O, +K | m |
| TP-R3 | 91.57 | 787.4582 | 787.4608 | C42H68O12Na | −2H, +O | vw |
| TP-R4 | 108.00 | 789.4754 | 789.4764 | C42H70O12Na | +O | w |
| TP-R5 | 118.56 | 771.4633 | 771.4659 | C42H68O11Na | −2H | vw |
| SAL | 142.61 | 773.4815 | 773.4815 | C42H70O11Na | vs | |
| RLM | ||||||
| TP-H1 | 44.33 | 821.4445 | 821.4453 | C42H70O13K | −Na, +2O, +K | vs |
| TP-H2 | 53.60 | 819.4307 | 819.4296 | C42H68O13K | −Na, −2H, +2O, +K | m |
| TP-H3 | 61.44 | 821.4439 | 821.4453 | C42H70O13K | −Na, +2O, +K | vs |
| TP-H4 | 65.20 | 821.4408 | 821.4453 | C42H70O13K | −Na, +2O, +K | s |
| TP-H5 | 69.91 | 819.4313 | 819.4296 | C42H68O13K | −Na, −2H, +2O, +K | w |
| TP-H6 | 81.35 | 805.4508 | 805.4504 | C42H70O12K | −Na, +O, +K | vs |
| TP-H7 | 86.37 | 803.4409 | 803.4347 | C42H68O12K | −Na, −2H, +O, +K | m |
| TP-H8 | 90.00 | 819.4582 | 819.4507 | C42H68O14Na | −2H, +3O | vw |
| TP-H9 | 91.57 | 787.4595 | 787.4608 | C42H68O12Na | −2H, +O | vw |
| TP-H10 | 102.10 | 787.4577 | 787.4608 | C42H68O12Na | −H2O, +2O | w |
| TP-H11 | 108.00 | 789.4707 | 789.4764 | C42H70O12Na | +O | vw |
| SAL | 142.61 | 773.4815 | 773.4815 | C42H70O11Na | w | |
Figure 5Overview of all TPs of SAL found in/by RLM and HLM assays; left hand; the potassium-based TPs; right hand; the sodium-based TPs. Numbers correspond to compounds presented in Table 3. Three regions of SAL are highlighted as modification area by dotted circles, the blue circle contains the carboxy-end, the red circle contains the spiroketal-end, and the green circle the carbonyl group.
Parameters of the ESI-HRMS for the ECR/MS measurements.
| Experiments Parameters | Mass Range Parameters | ||
|---|---|---|---|
| gas temperature | 400 °C | collision energy | 40 V |
| ion source gas 1 (nitrogen) | 55 L/min | declustering potential | 80 V |
| ion source gas 2 (nitrogen | 55 L/min | mass range | 100–800 Da |
| curtain gas (nitrogen) | 45 L/min | ||
| ion spray voltage floating | +5500 V | ||
Parameters of the ESI-HRMS for the LC-HRMS measurements.
| Experiments Parameters | Mass Range Parameters | ||
|---|---|---|---|
| gas temperature | 400 °C | MS 1 | |
| ion source gas 1 (nitrogen) | 50 L/min | collision energy | 10 V |
| ion source gas 2 (nitrogen) | 55 L/min | declustering potential | 80 V |
| curtain gas (nitrogen) | 45 L/min | mass range | 100–900 Da |
| ion spray voltage floating | +5500 V | MS 2 | |
| gas temperature | 400 °C | collision energy | 85 V (LM) |
| collision energy spread | 20 V | ||
| declustering potential | 80 V | ||
| mass range | 100–900 Da | ||